pseudoxanthoma elasticum pxe genetic disease causes mineralization elastic fibers tissues common problems arise skin eyes later blood vessels form premature pxe caused autosomal recessive mutations gene short arm chromosome usually pseudoxanthoma elasticum affects skin first often childhood early small yellowish papular lesions form cutaneous laxity mainly affect neck axillae armpits groin flexural creases inside parts elbows skin may become lax redundant many individuals oblique mental creases horizontal grooves pxe first affects retina dimpling bruch membrane thin membrane separating blood vesselrich layer pigmented layer retina visible ophthalmologic called peau dorange french term meaning skin orange eventually mineralization elastic fibers bruch membrane create cracks called angioid streaks radiate optic nerve angioid streaks cause distortion vision even cross foveal area symptom present almost pxe patients usually noticed years onset cutaneous lesions cracks may allow small blood vessels originally held back bruchs membrane penetrate retina blood vessels sometimes leak retinal hemorrhages may lead loss central vision vision loss major issue many pxe pxe may affect gastrointestinal cardiovascular systems gastrointestinal bleeding rare symptom usually involved bleeding stomach circulatory system intermittent claudication condition cramping pain leg induced exercise prominent later stages coronary artery disease may develop leading angina myocardial infarction heart cerebral ischemia pxe caused small vessel occlusive disease rare neurological complications may include intracranial aneurysms subarachnoid intracerebral clinical cases pseudoxanthoma elasticum detectable mutations mutations almost parts gene described types missense nonsense splice alteration insertion small deletion large deletion although reports autosomal dominant inheritance inheritance typically autosomal recessive parents need carriers chance child inherit abnormal copies gene therefore develop strong genetic linkage found mutations gene codes protein membrane transporter large atpbinding cassette transporter family protein expressed organs mainly liver kidney mediates atp release liver main source circulating pyrophosphate ppi individuals affected pxe strongly reduced plasma ppi levels explaining mineralization one study suggested mutations causing total absence protein caused severe could confirmed subsequent case given variations age onset severity likely unknown risk factors genetic environmental lifestyle may premature atherosclerosis also associated mutations gene even without syndrome almost indistinguishable hereditary pxe described patients hemoglobinopathies sicklecell disease thalassemia poorly understood addition appears another pxelike syndrome similar phenotype result problems another gene gammaglutamyl mutations also cause generalized arterial calcification cases pxe mutations found genes may pxe mineralization accumulation calcium minerals fragmentation elastincontaining fibers connective tissue primarily midlaminar layer dermis bruchs membrane midsized recent studies confirmed pxe metabolic disease features arise metabolites vitamin k reach peripheral low levels ppi cause mineralization peripheral diagnostic criteria pxe typical skin biopsy appearance presence angioid streaks retina criteria established consensus clinicians researchers biennial research meeting pxe research confirmed consensus criteria state definitive pxe characterized two pathogenic mutations ocular findings angioid streaks dd peau orange individual years age together skin findings confirmed treatment directly interferes disease cosmetic surgery remove excessive skin used improve aesthetic appearance pxe nonlifethreatening nature symptoms used one critical symptom pxe choroidal neovascularization lead deterioration central vision photodynamic therapy used treatment replaced endothelial growth factor vegf inhibitors bevacizumab ranibizumab efficacy similar use treatment agerelated macular limit cardiovascular symptoms reduction cardiovascular risk factors lifestyle changes generally clinicians recommend avoidance nonsteroidal antiinflammatory drugs nsaids increase bleeding risk aspirin ibuprofen prevent eye gastrointestinal formerly dietary restriction calcium tried benefit fact accelerated mineralization number potential treatments currently tested undergone testing including tissuenonspecific alkaline phosphatase given heterozygous mutations result symptoms pxe disease candidate gene therapy initial proofofprinciple experiments done mice relieved symptoms pxe gene therapy treatments many hurdles must come including insuring treatment longlasting reducing risk insertional mutagenesis severe immune reported prevalence pseudoxanthoma elasticum females twice likely affected males disease occurs ethnicities afrikaners likely pxe result founder effect ie higher prevalence small group people afrikaners first description pxe distinguished xanthoma conditions dr ferdinandjean darrier eponym gr√∂nbladstrandberg syndrome used older literature two physicians made discoveries disease pxe distinction disease layperson discover mutated gene gene mutation discovered simultaneously four research teams published time principal investigators order date publication jouni arthur charles klaus gene patented charles boyd katalin csiszar olivier lesaux zsolt urban sharon terry assigned pxe international coinventors filing supreme court united states declared genes may pxe international freely licensed gene lab clinical testing research pxe international continues hold maintain patents diagnosis treatment pxe international support organization founded patrick sharon following diagnosis two children registry affected individuals pseudoxanthoma elasticum posterior lateral neck pseudoxanthoma elasticum left axillary fold see also templatecongenital malformations deformations skin appendages templatephakomatoses templatepigmentation disorders templatedna replication repairdeficiency disorder